Rare diseases
Investigational molecules
Locations
Study of nedosiran for patients with primary hyperoxaluria type 1 and severe kidney impairment with or without dialysis
ItalyStudy of tuvusertib combined with niraparib or lartesertib for patients with ovarian cancer that worsened after previous PARP inhibitor treatment
ItalyStudy of GSK3965193 and Bepirovirsen for People Living with Chronic Hepatitis B Infection and Healthy Participants
ItalyA study testing NNC0194-0499, cagrilintide, and semaglutide alone or combined to treat liver damage in people with alcohol-related liver disease
ItalyStudy of Erenumab Compared to Placebo for Children and Adolescents with Episodic Migraine to Reduce Monthly Migraine Days
ItalyA Study of Erenumab Compared to Placebo for Children and Teenagers With Chronic Migraine to Test How Well It Works and How Safe It Is
ItalyItalyA study comparing cagrilintide and semaglutide combination to semaglutide, cagrilintide, and placebo in adults with type 2 diabetes on metformin
ItalyStudy of encaleret compared to standard care in patients with autosomal dominant hypocalcemia type 1
ItalyA study testing tozorakimab for long-term treatment of chronic obstructive pulmonary disease in former smokers with repeated flare-ups
ItalyA study testing brepocitinib compared to placebo for adults with dermatomyositis to see if it works and is safe
ItalyA Study of PF-07868489 Safety and Effectiveness in Adults with Pulmonary Arterial Hypertension Who Participated in a Previous PF-07868489 Trial
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
